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Extracellular vesicles in the host-parasite interaction 19 
In recent years, extracellular vesicles (EVs) have been accepted as a new intercellular 20 
communication system that mediate the transfer of proteins, lipids, mRNA, microRNA 21 
and other non-coding RNA species. Special attention has been paid to the role of EVs in 22 
the establishment and progression of human diseases. Indeed, perturbing EV production 23 
to modulate their pathological effects is an attractive therapeutic option that has been 24 
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successful in a number of diseases, including cancer (1). To the same extent, several 25 
studies have described the contribution of parasite-derived EVs to the modulation of the 26 
host immune system (2-4) or the pathological effects on host cells (5). Tools such as 27 
transcriptomics and proteomics, have been particularly useful for identification of the 28 
immunomodulatory molecules that parasites package into EVs (6). A better 29 
understanding of how parasite EVs are produced and interact with host cells may open 30 
new avenues for parasite control, since the selective inhibition of these would prevent the 31 
delivery of potent immunomodulators that induce a host immune phenotype that favors 32 
parasite survival. 33 
It is in this context that we established a definitive characterization of the total 34 
secretome of the zoonotic parasite Fasciola hepatica (6), one of the causative agents of 35 
the trematode foodborne disease known as Fascioliasis. Whilst primarily regarded as a 36 
disease of livestock, it is estimated that F. hepatica infects between 2 and 17 million 37 
people worldwide, with a further 180 million living at risk of infection (7). Resistance to 38 
triclabendazole, the frontline chemical treatment against Fasciola, is rapidly spreading 39 
and highlights the need for novel control strategies against the parasite (8).  40 
 41 
Characterization of the EVs released by Fasciola hepatica 42 
EVs released by the parasite during in vitro culture were isolated using ultracentrifugation 43 
and ultrafiltration and subsequently analyzed by transmission electron microscopy (TEM) 44 
and mass spectrometry. One of the pivotal findings was that Fasciola secretes at least two 45 
sub-populations of EVs of varying size that bear different cargo molecules and may be 46 
released from distinct sites within the parasite. TEM revealed that the larger EVs are 47 
released from the specialized cells that line the parasite gastrodermus and are specifically 48 
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enriched in the zymogen of the 37 kDa cathepsin L peptidase, which mainly performs a 49 
digestive function (9). Proteomics and transcriptomics data provided insight into 50 
molecular origin of the smaller exosome-like EV population. Whilst a previous exosome 51 
characterization study described only the total vesicular content (10), we wanted to obtain 52 
a more detailed picture of the vesicle architecture. Thus, we performed a differential 53 
extraction of membrane associated proteins – more likely to participate in interactions 54 
with host cells – and those packaged as cargo – envisaged to be delivered into host cells. 55 
Mass spectrometry analysis revealed a significant number of proteins belonging to the 56 
ESCRT pathway of EV biogenesis and vesicular transport. Together with the abundance 57 
of shared tegumental proteins (11), these results suggested that at least some EVs from 58 
Fasciola originate from multivesicular bodies within the tegumental syncytium before 59 
being shed from the apical plasma membrane. Furthermore, transcriptomics analysis 60 
indicated that whilst the molecular “machinery” required for EV biogenesis is 61 
constitutively expressed (albeit at low levels) across the intra-mammalian developmental 62 
stages of the parasite, the cargo molecules packaged within the EVs are developmentally 63 
regulated. This suggests that there is a constant release of EVs containing effector 64 
molecules finely tuned to the defensive needs of the developing parasite as it migrates 65 
through various host tissues.  66 
 67 
Future research directions 68 
Although this study provided insight into the mechanisms that helminth parasites 69 
use to produce EVs, it raised a considerable number of questions that need to be addressed 70 
before designing a rational therapeutic approach for this or other helminth parasites 71 
(reviewed by 12). Our proteomics data largely supports an ESCRT-dependent origin for 72 
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the exosome-like EVs released by F. hepatica (Table 1). However, further research is 73 
needed to determine the specific roles of individual pathway members during exosome 74 
biogenesis in liver fluke – e.g. by RNAi mediated gene silencing, which is functional in 75 
this parasite (13). Additionally, before members from these pathways can be selected as 76 
possible targets for anti-parasite drugs, it remains to be elucidated whether mammalian 77 
exosome biogenesis pathways are conserved in F. hepatica or if novel routes are used by 78 
the parasite. The presence of orthologues from ESCRT-independent pathways, such as 79 
sphingomyelinase and various members of the tetraspanin family in its secretome (6, 80 
Table1) could indicate that F. hepatica uses hybrid routes for EV release as have been 81 
described in some mammalian cell types (14). However, this may also be due to the 82 
heterogeneity of vesicle populations in the isolated EVs. The lack of specific markers to 83 
distinguish EV sup-populations is a common issue in the field (15) and therefore, to 84 
establish a broader set of markers would help to discriminate EV populations and track 85 
down their site(s) of production and release from the parasite. We found that the zymogen 86 
of cathepsin L, specifically enriched in the larger EVs released by the parasite, constitutes 87 
a potential marker for this type of vesicle. Our differential extraction approach, which 88 
separated membrane-associated proteins from those packaged into the lumen of exosome-89 
like vesicles, helped to identify exosomal markers common to many species as well as 90 
potential parasite-specific molecules, such as tetraspanins.  91 
Transcriptome analysis indicated that members of EV biogenesis pathways are 92 
constitutively expressed during the intra-mammalian developmental stages of the 93 
parasite. This is in agreement with reports of constitutive release of exosomes via the 94 
endosomal pathway in mammalian cells (16). On the other hand, shedding of 95 
microvesicles from the plasma membrane usually occurs in response to a stimulus. It is 96 
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well documented that F. hepatica, as well as other platyhelminth and nematode parasites, 97 
shed vesicles (usually referred to as blebs) from their cuticle/tegument in response to drug 98 
treatment or humoral immune challenge (17, 18). Although it has been suggested that 99 
blebbing is an attempt by helminths to replenish tegument that has been lost/damaged due 100 
to drug action (19), this mechanisms might constitute a defensive response of the parasite 101 
to reduce drug effective concentrations by packing them into vesicles that are 102 
immediately disposed of. To determine whether the molecular pathways involved in bleb 103 
production are the same as microvesicle production could provide a better understanding 104 
of drug resistance in helminth parasites, and a means to counter it. 105 
Whilst EVs secreted by helminths can be internalized by host cells and regulate 106 
host immune and inflammatory responses (2-5, 10), it is unclear to what extent Fasciola 107 
EVs contribute to maintaining a Th2/regulatory environment that is permissive to fluke 108 
survival and reproduction. Once we gain a better understanding of these issues, the 109 
selective disruption of key pathways involved in EV biogenesis, or blocking the EV-110 
driven delivery of parasite immunomodulators to host cells, might prove to be an efficient 111 
way to achieve parasite control in the future. 112 
 113 
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Table 1 Summary of proteins identified in adult F. hepatica extracellular vesicles that 192 
are involved in EV biogenesis in mammalian cells. 193 
Protein Function EV type 
subtype    
ESCRT-dependent pathway 
TSG101 ESCRT-I component Exo & MV 
CHMP2A ESCRT-III component Exo 
CHMP5 ESCRT-III component Exo 
CHMP1A,B ESCRT-III component Exo & MV 
IST1 ESCRT-III component Exo 
VPS4 EV abscission Exo & MV 
VTA1 VPS4 cofactor Exo 
ALIX/PDCD6IP ILV formation/cargo sorting Exo 
Syntenin ILV formation/cargo sorting Exo 
   
ESCRT-independent pathway 
Sphingomyelinase Ceramide-dependent ILV formation Exo & MV 
CD63 antigen ILV formation/cargo sorting Exo 
   
Vesicle trafficking and membrane fusion/remodelling 
Rab8a Fusion of MVB with the PM Exo 
Rab11 Fusion of MVB with the PM Exo 
Rab27 Fusion of MVB with the PM Exo 
Ral-1/Ral-A Fusion of MVB with the PM Exo 
Rho1 GTPase Signal-induced cytoskeletal regulation MV & Bleb 
Synaptotagmin t-SNARE Exo 
VAMP7 v-SNARE Exo 
Phospholipid translocases PM curvature  MV 
Phospholipases Signal-induced cytoskeletal regulation Exo & MV 
vATPase (V0) Fusion of MVB with the PM Exo 
Exo, exosomes; MV, microvesicles; ILV, intraluminal vesicle; MVB, multivesicular 
body; PM, plasma membrane. 
 194 
